22 May 2013
Keywords: roche, initiates, ph, ii, trial, novel, hcv
Article | 23 October 2006
Swiss drug major Roche has initiated the first Phase II study to evaluate its new polymerase inhibitor, R1626, for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 October 2006
© 2013 thepharmaletter.com